ClinicalTrials.govpublic full text
Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers
prostate cancer, hormone resistant prostate cancer, neuro-endocrine marker, carboplatin-etoposide combination, neuro-endocrine differentiation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906667
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.